Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025
呼吸道合胞病毒预防产品引入后,美国婴幼儿呼吸道合胞病毒住院率的中期评估——2024年10月至2025年2月
期刊:Mmwr-Morbidity and Mortality Weekly Report
影响因子:17.3
doi:10.15585/mmwr.mm7416a1
Patton, Monica E; Moline, Heidi L; Whitaker, Michael; Tannis, Ayzsa; Pham, Huong; Toepfer, Ariana P; Taylor, Christopher A; Goldstein, Leah; Reingold, Arthur; Kirley, Pam Daily; Alden, Nisha B; Kawasaki, Breanna; Meek, James; Kim, Daewi; Witt, Lucy S; Openo, Kyle P; Ryan, Patricia A; Mumm, Erica; Lynfield, Ruth; Salazar-Sanchez, Yadira; Pacheco, Francesca; Keating, Fiona; Anderson, Bridget J; Tesini, Brenda L; Felsen, Christina B; Sutton, Melissa; Thomas, Ann; Schaffner, William; Talbot, H Keipp; Harbi, Khalil; Doran, Emma; Weinberg, Geoffrey A; Staat, Mary A; Payne, Daniel C; Halasa, Natasha B; Stewart, Laura; Boom, Julie A; Sahni, Leila C; Klein, Eileen J; Englund, Janet A; Williams, John V; Michaels, Marian G; Schuster, Jennifer E; Selvarangan, Rangaraj; Szilagyi, Peter G; Havers, Fiona P; Dawood, Fatimah S